aspirin and pd 0348292

aspirin has been researched along with pd 0348292 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baxi, SM; Karnicki, K; Leadley, RJ; McBane, RD; Wysokinski, W1
Baxi, S; Karnicki, K; Leadley, RJ; McBane, RD; Peterson, T; Wysokinski, W1

Other Studies

2 other study(ies) available for aspirin and pd 0348292

ArticleYear
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:3

    Topics: Administration, Oral; Angioplasty; Animals; Antithrombin III; Aspirin; Clopidogrel; Constriction, Pathologic; Disease Models, Animal; Drug Therapy, Combination; Female; Iliac Vein; Preoperative Care; Probability; Pyridones; Pyrrolidines; Random Allocation; Reference Values; Stents; Ticlopidine; Treatment Outcome; Vascular Patency; Venous Thrombosis

2008
Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:4

    Topics: Administration, Oral; Animals; Aspirin; Bleeding Time; Blood Coagulation; Carotid Artery Injuries; Carotid Artery Thrombosis; Clopidogrel; Disease Models, Animal; Factor Xa Inhibitors; Female; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridones; Pyrrolidines; Sus scrofa; Thrombosis; Ticlopidine

2008